Article ID Journal Published Year Pages File Type
8734626 Revista Brasileira de Hematologia e Hemoterapia 2017 7 Pages PDF
Abstract
Everolimus was found to provide a response in a group of patients with refractory or relapsed Hodgkin's lymphoma who had adequate tolerability to the drug.
Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
, , , , , , , , ,